Skip to main content
. 2017 Aug 19;313(6):H1109–H1118. doi: 10.1152/ajpheart.00153.2017

Fig. 4.

Fig. 4.

Chronic A61603 treatment improved contraction and reduced cardiomyocyte necrosis. Shown is a summary of averaged data for right ventricular (RV) fractional shortening (FS; black circles) and maximum myofilament force (Fmax; gray triangles) relative to the serum level of cardiac troponin I (cTnI; from data shown in Figs. 13). Bleomycin (Bleo) increased cTnI and caused proportional reductions in both RV FS and Fmax. These changes were attenuated by concurrent treatment with A61603.